185 related articles for article (PubMed ID: 8126833)
1. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia.
Kasabian NG; Vlachiotis JD; Lais A; Klumpp B; Kelly MD; Siroky MB; Bauer SB
J Urol; 1994 Apr; 151(4):944-5. PubMed ID: 8126833
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children.
Amark P; Bussman G; Eksborg S
Eur Urol; 1998 Aug; 34(2):148-53. PubMed ID: 9693251
[TBL] [Abstract][Full Text] [Related]
3. Intravesical oxybutynin chloride: experience with 42 patients.
Weese DL; Roskamp DA; Leach GE; Zimmern PE
Urology; 1993 Jun; 41(6):527-30. PubMed ID: 8516987
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
[TBL] [Abstract][Full Text] [Related]
5. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
Greenfield SP; Fera M
J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
[TBL] [Abstract][Full Text] [Related]
6. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride.
Moisey CU; Stephenson TP; Brendler CB
Br J Urol; 1980 Dec; 52(6):472-5. PubMed ID: 7006730
[TBL] [Abstract][Full Text] [Related]
7. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration.
Kasabian NG; Bauer SB; Dyro FM; Colodny AH; Mandell J; Retik AB
Am J Dis Child; 1992 Jul; 146(7):840-3. PubMed ID: 1496955
[TBL] [Abstract][Full Text] [Related]
8. Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida.
Ferrara P; D'Aleo CM; Tarquini E; Salvatore S; Salvaggio E
BJU Int; 2001 May; 87(7):674-8. PubMed ID: 11350411
[TBL] [Abstract][Full Text] [Related]
9. Intravesical oxybutynin for spinal cord injury patients.
Szollar SM; Lee SM
Spinal Cord; 1996 May; 34(5):284-7. PubMed ID: 8963976
[TBL] [Abstract][Full Text] [Related]
10. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
[TBL] [Abstract][Full Text] [Related]
11. Control of detrusor hyperreflexia by the intravesical instillation of oxybutynine hydrochloride.
Madersbacher H; Jilg G
Paraplegia; 1991 Feb; 29(2):84-90. PubMed ID: 2023781
[TBL] [Abstract][Full Text] [Related]
12. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability.
Moore KH; Hay DM; Imrie AE; Watson A; Goldstein M
Br J Urol; 1990 Nov; 66(5):479-85. PubMed ID: 2249115
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
Franco I; Horowitz M; Grady R; Adams RC; de Jong TP; Lindert K; Albrecht D
J Urol; 2005 Jan; 173(1):221-5. PubMed ID: 15592080
[TBL] [Abstract][Full Text] [Related]
14. Intravesical oxybutynin chloride and clean intermittent catheterisation in patients with neurogenic vesical dysfunction and decreased bladder capacity.
Prasad KV; Vaidyanathan S
Br J Urol; 1993 Nov; 72(5 Pt 2):719-22. PubMed ID: 8281402
[TBL] [Abstract][Full Text] [Related]
15. Expanded followup of intravesical oxybutynin chloride use in children with neurogenic bladder.
Kaplinsky R; Greenfield S; Wan J; Fera M
J Urol; 1996 Aug; 156(2 Pt 2):753-6. PubMed ID: 8683776
[TBL] [Abstract][Full Text] [Related]
16. Effect of intermittent urethral catheterization and oxybutynin bladder instillation on urinary continence status and quality of life in a selected group of spinal cord injury patients with neuropathic bladder dysfunction.
Vaidyananthan S; Soni BM; Brown E; Sett P; Krishnan KR; Bingley J; Markey S
Spinal Cord; 1998 Jun; 36(6):409-14. PubMed ID: 9648197
[TBL] [Abstract][Full Text] [Related]
17. Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia.
Goessl C; Knispel HH; Fiedler U; Härle B; Steffen-Wilke K; Miller K
Urology; 1998 Jan; 51(1):94-8. PubMed ID: 9457296
[TBL] [Abstract][Full Text] [Related]
18. Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury.
Pannek J; Sommerfeld HJ; Bötel U; Senge T
Urology; 2000 Mar; 55(3):358-62. PubMed ID: 10699610
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo.
Thüroff JW; Bunke B; Ebner A; Faber P; de Geeter P; Hannappel J; Heidler H; Madersbacher H; Melchior H; Schäfer W
J Urol; 1991 Apr; 145(4):813-6; discussion 816-7. PubMed ID: 2005707
[TBL] [Abstract][Full Text] [Related]
20. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride.
Bary PR; Moisey CU; Stephenson TP; Brendler CB
Prog Clin Biol Res; 1981; 78():313-9. PubMed ID: 7038709
[No Abstract] [Full Text] [Related]
[Next] [New Search]